Literature DB >> 30676849

Spleen-Associated Effects on Immunity in Hepatitis B Virus-Related Cirrhosis with Portal Hypertension.

Na Huang1,2, Fan Pu Ji1,3,4, Shu Zhang1,2,3, Zhenzhen Li1, Jun Li1,2, Rui Zhou1,2,3, Shaoying Zhang1, Wei Wei1, Liang Li1, Haiyan Chen1,2, Baohua Li1,2, Guangyao Kong1, Jun Yang1,2,5, Zongfang Li1,2,3.   

Abstract

Our study aimed to investigate the histologic and immunological changes of portal hypertension (PH) pre- and postsplenectomy in hepatitis B virus (HBV)-related cirrhosis. Peripheral blood samples were obtained from 30 patients with HBV-related cirrhosis and PH at pre- and postsplenectomy time points and from 15 healthy subjects. Spleen tissue specimens were collected from 15 of the patients with HBV-related cirrhosis and from 8 control patients who had undergone splenectomy due to trauma. Immunohistochemical staining was performed to evaluate the immune effector cells and the expression of negative immune regulators. Flow cytometry was used to investigate the immunophenotypes and percentages. The spleen of cirrhotic patients with PH showed extensive depletion of splenic CD4, CD8, and human leukocyte antigen DR cells along with overexpression of the inhibitory receptors programmed death-1 (PD-1) and T cell immunoglobulin domain and mucin domain-3 and their ligands (PD-L2 and galectin-9). Peripheral blood of patients with PH showed remarkable decrease in proportions of CD8 T cell and natural killer (NK) cells and increase in regulatory T (Treg) cells, as well as high expression of PD-1 in CD4/8 T cells. Compared with presplenectomy patients, cirrhotic patients with PH showed increased proportions of CD8 and NK cells, decreased proportion of Treg cells, and decreased expression of PD-1 in peripheral blood CD4/8 T cells after splenectomy. PH-spleen could lead to peripheral tolerance and immunosuppression in HBV cirrhotic patients, and splenectomy may cause beneficial immunological changes.

Entities:  

Keywords:  CD4 T cell; CD8 T cell; NK cell; hepatitis B virus; immunity; portal hypertension; programmed death-1; spleen

Mesh:

Year:  2019        PMID: 30676849     DOI: 10.1089/jir.2018.0121

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  3 in total

1.  Splenectomy improves liver fibrosis via tumor necrosis factor superfamily 14 (LIGHT) through the JNK/TGF-β1 signaling pathway.

Authors:  Qing-Shan Liang; Jian-Gang Xie; ChaoPing Yu; ZhuSheng Feng; JingChang Ma; Yuan Zhang; Dong Wang; JianGuo Lu; Ran Zhuang; Jikai Yin
Journal:  Exp Mol Med       Date:  2021-03-03       Impact factor: 8.718

2.  Splenic CD4+ and CD8+ T-cells highly expressed PD-1 and Tim-3 in cirrhotic patients with HCV infection and portal hypertension.

Authors:  Na Huang; Rui Zhou; Haiyan Chen; Shu Zhang; Jun Li; Wei Wei; Jin Sun; Song Ren; Baohua Li; Hong Deng; Jun Yang; Fanpu Ji; Zongfang Li
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

3.  Laparoscopic splenectomy and devascularization for massive splenomegaly in portal hypertensive patients: a retrospective study of a single surgical team's experience with 6-year follow-up data.

Authors:  Dong Wang; Xiao Chen; Ling Lv; Tao Yang; Bo Huang; Yanlong Cao; Jianguo Lu; Jikai Yin
Journal:  Ann Transl Med       Date:  2022-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.